ENGINEERING A HEMOCOMPATIBLE MICROFLUIDIC PLATFORM FOR PRO-THROMBOTIC DRUG EVALUATION
Shouyuan Jiang, Deepu Ashok, Tiffany Goh, Marcela Bilek, Anna Waterhouse · container not stated · 2025
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
· OpenAlex · conference-paper · 2025
Abstract
Standard Thrombosis-on-a-chip platforms exhibit high baseline thrombogenicity, limiting their use in evaluating pro-thrombotic drugs.Here, we present a blood-compatible microfluidic platform engineered using novel plasma surface treatment to create low-thrombogenic surfaces.The modified microfluidic channel significantly reduced platelet adhesion and fibrin formation under low-heparin conditions, enabling accurate assessment of pro-thrombotic responses in whole blood (Figure 1).
Open the resolved locator · 10.70477/nmif5952
Metadata licence: OpenAlex metadata (CC0)